Nanalysis Scientific Corp.

Equities

NSCI

CA63000Y1034

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 01:25:42 10/05/2024 am IST			5-day change	1st Jan Change
0.475 ^CAD	-1.04%		+15.85%	+26.67%

30/04	Transcript : Nanalysis Scientific Corp., 2023 Earnings Call, Apr 30, 2024
29/04	Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023

February 06, 2024 at 07:13 pm IST

Nanalysis Scientific Corp. provided earnings guidance for the fourth quarter 2023. The company able to achieve fourth quarter unaudited revenues of between $9.3 million and $9.8 million, constituting a new record quarter for Nanalysis.

Latest news about Nanalysis Scientific Corp.

Transcript : Nanalysis Scientific Corp., 2023 Earnings Call, Apr 30, 2024	30/04
Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Transcript : Nanalysis Scientific Corp., Q4 2023 Earnings Call, Apr 29, 2024	30/04
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director	10/04	CI
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances	04/04	CI
Nanalysis Scientific Corp. announced that it has received CAD 1 million in funding	20/03	CI
Nanalysis Scientific Announces Financings	07/03	MT
Nanalysis Scientific Brief: Announcing Up to $5 Million 'Best Efforts Prospectus Exempt Offering' Pursuant to the Listed Issuer Exemption and Up to $1 Million Concurrent Private Placement	07/03	MT
Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding	06/03	CI
Nanalysis Scientific Corp. to Seeks Acquisitions	13/02	CI
Transcript : Nanalysis Scientific Corp. - Special Call	13/02
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023	06/02	CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 30, 2023	30/11
Nanalysis Scientific Third-Quarter Loss Widens as Sales Rise	30/11	MT
Nanalysis Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11	CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 29, 2023	30/11
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 25, 2023	25/23/25
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 24, 2023	25/23/25
Nanalysis Scientific Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/23/25	CI
Nanalysis Scientific Enters into New Credit Facility with ATB Financial	30/23/30	MT
Transcript : Nanalysis Scientific Corp. - Shareholder/Analyst Call	28/23/28
Transcript : Nanalysis Scientific Corp. - Special Call	21/23/21
Transcript : Nanalysis Scientific Corp., Q1 2023 Earnings Call, May 25, 2023	26/23/26
Nanalysis Scientific Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding	03/23/03	CI

Chart Nanalysis Scientific Corp.

Duration

Period

More charts

Company Profile

Nanalysis Scientific Corp. is a Canada-based patent-protected technology company that develops, manufactures and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. The Company operates through four segments: Nanalysis, RS2D, KâPrime and Corporate. The Companyâs subsidiaries include Nanalysis Corp., Nanalysis GmbH, RS2D S.A.S., One Moon Scientific (OMS), K'(Prime) Technologies Inc., KPrime Group USA, KPrime Technologies, Quad Systems AG and Quad Systems Ltd. RS2D S.A.S. is a technology company that is specialized in the designing of compact, electronics components for a range of precision analytical MR instruments, including both NMR and magnetic resonance imaging (MRI). OMS is a software company, which is specialized in a suite of software tools to streamline and automate magnetic resonance data analysis and management.

Sector

Advanced Medical Equipment & Technology

Calendar

29/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.475 CAD

Average target price

1.2 CAD

Spread / Average Target

+152.63%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NANALYSIS SCIENTIFIC CORP.	+26.67%	39.23M
THERMO FISHER SCIENTIFIC	+8.88%	221B
DANAHER CORPORATION	+8.68%	186B
INTUITIVE SURGICAL, INC.	+14.25%	137B
BOSTON SCIENTIFIC CORPORATION	+28.18%	109B
EDWARDS LIFESCIENCES CORPORATION	+14.65%	52.68B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.48%	50.86B
AGILENT TECHNOLOGIES, INC.	+4.39%	42.53B
GE HEALTHCARE TECHNOLOGIES INC.	+7.00%	37.76B
RESMED, INC.	+26.06%	31.86B

Other Advanced Medical Equipment & Technology